Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Amneal Pharmaceuticals In...

    NASDAQ: AMRX · Real-Time Price · USD
    9.43
    0.04 (0.43%)
    At close: Aug 15, 2025, 12:25 PM

    Amneal Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 110.55M 91.54M 25.98M 247.79M
    Short-Term Investments
    		 1.87M 2.2M 1.82M 1.17M
    Long-Term Investments
    		 35.92M 37.09M 85.59M n/a
    Other Long-Term Assets
    		 24.21M 18.43M 17.63M 20.61M
    Receivables
    		 808.56M 645.66M 796.91M 694.74M
    Inventory
    		 612.45M 581.38M 530.74M 489.39M
    Other Current Assets
    		 7.87M 39.49M 64.37M 41.95M
    Total Current Assets
    		 1.59B 1.38B 1.41B 1.52B
    Property-Plant & Equipment
    		 523.69M 550.14M 589.36M 639M
    Goodwill & Intangibles
    		 1.33B 1.49B 1.69B 1.76B
    Total Long-Term Assets
    		 1.91B 2.09B 2.39B 2.42B
    Total Assets
    		 3.5B 3.47B 3.8B 3.94B
    Account Payables
    		 258.69M 143.57M 166.84M 131.08M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 324.21M 213.13M 89.96M 30.61M
    Other Current Liabilities
    		 136.1M 227.43M 263.11M 277.77M
    Total Current Liabilities
    		 1.13B 846.6M 752.8M 677.24M
    Long-Term Debt
    		 2.16B 2.43B 2.63B 2.72B
    Other Long-Term Liabilities
    		 163.33M 83.06M 122.07M 65.43M
    Total Long-Term Liabilities
    		 2.42B 2.61B 2.84B 2.9B
    Total Liabilities
    		 3.55B 3.45B 3.59B 3.57B
    Total Debt
    		 2.59B 2.75B 2.85B 2.88B
    Common Stock
    		 3.1M 3.07M 3.04M 3.01M
    Retained Earnings
    		 -607.06M -490.18M -406.18M -276.2M
    Comprehensive Income
    		 -65.51M -32.35M 9.94M -24.83M
    Shareholders Equity
    		 -109.27M 19.78M 298.42M 360.34M
    Total Investments
    		 37.79M 39.29M 87.41M 1.17M

    Add to Watchlist